Soluble fibre oat and barley β-glucan enriched products: Can we predict cholesterol-lowering effects?

British Journal of Nutrition

Volumn 97, Issue 6, 2007, Pages 1049-1050

  Poppitt, Sally D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BARLEY; BILE ACID SYNTHESIS; BRAN; CARDIOVASCULAR RISK; CEREAL; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; FOOD PROCESSING; FOOD STORAGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; MOLECULAR WEIGHT; NONHUMAN; NOTE; NUTRIENT SUPPLY; OAT; PREDICTION; RICE; RISK REDUCTION; RYE; SOLUBILITY; WHEAT;

AVENA SATIVA; BETA-GLUCANS; DIETARY FIBER; FOOD, FORTIFIED; HORDEUM; HUMANS; HYPERCHOLESTEROLEMIA; PROGNOSIS; SOLUBILITY; TREATMENT OUTCOME;

HORDEUM;

EID: 34250381230     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507690023     Document Type: Note

References (23)

1. Beer MU, Arrigoni E & Amadò R (1995) Effects of oat gum on blood cholesterol levels in healthy young men. Eur J Clin Nutr 49, 517-522.
2. Beer MU, Wood PJ, Weisz J & Fillion N (1997) Effect of cooking and storage on the amount and molecular weight of (1-3)(1-4)-beta-D-glucan extracted from oat products by an in vitro digestion system. Cereal Chem 74, 705-709.
3. Behall KM, Schofield DJ & Hallfrisch J (2004) Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. Am J Clin Nutr 80, 1185-1193.
4. Brown L, Rosner B, Willett WW & Sacks FM (1999) Cholesterol-lowering effects of dietary fibre: A meta-analysis. Am J Clin Nutr 69 30-42.
5. Food and Drug Administration (2006) Food Labeling: 'Health Claims: Soluble dietary fiber from certain foods and coronary heart disease'. In Code of Federal Regulation Title 21 Part 101 (accessed 11 Jan 2007), http://www.fda.gov/ohrms/dockets/98FR/04p-0512-nfr0001.pdf
6. Frank J, Sundberg B, Kamal-Eldin A, Vessby B & Aman P (2004) Yeast-leavened oat breads with high or low molecular weight beta-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans. J Nutr 134, 1394-1388.
7. Jensen M, Koh-Banerjee P, Hu F, Franz M, Sampson L & Gronboek M (2004) Intake of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr 80, 1492-1499.
8. Keogh GF, Cooper GJS, Mulvey TB, McArdle BH, Coles GD, Monro JA & Poppitt SD (2003) Randomized controlled crossover study of the effect of a highly b-glucan enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men. Am J Clin Nutr 78, 711-718.
9. Kerckhoffs D, Hornstra G & Mensink R (2003) Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 78, 221-227.
10. Keys A, Anderson JT & Grande F (1960) Diet-type (fats constant) and blood lipids in man. J Nutr 70, 257-266.
11. Leadbetter J, Ball MJ & Mann JI (1991) Effects of increasing quantities of oat bran in hypercholesterolemic people. Am J Clin Nutr 54 841-845.
12. Lia A, Hallmans G, Sandberg A-S, Sundberg B, Åman P & Andersson H (1995) Oat β-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am J Clin Nutr 62, 1245-1251.
13. Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE, Hennekens CH & Willett WC (1999) Whole-grain consumption and risk of coronary heart disease: Results from the Nurses' Health Study. Am J Clin Nutr 70, 412-419.
14. Lovegrove JA, Clohessy A, Milon H & Williams CM (2000) Modest doses of β-glucan do not reduce the concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 72, 49-55.
15. McLeary BV (2001) Measurement of dietary fibre components: The importance of enzyme purity, activity and specificity. In Advanced dietary fibre technology, pp. 89-105 [BV McLeary and L Prosky, editors]. London: Blackwell Science Ltd.
16. Mälkki Y, Autio K, Hanninen O, Myllymaki O, Pelkonen K, Suortti T & Törrönen R (1992) Oat bran concentrates: Physical properties of beta-glucan and hypocholesterolemic effects in rats. Cereal Chem 69, 647-653.
17. Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS & Story JA (1994) Mechanism of serum cholesterol reduction by oat bran. Hepatol 20, 1450-1457.
18. Naumann E, vanRees AB, Onning G, Oste R, Wydra M & Mensink RP (2006) Beta-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am J Clin Nutr 83, 601-605.
19. Keenan JM, Goulson M, Shamliyan T, Knutson N, Kolberg L & Curry L (2007) The effects of concentrated barley β-glucan on blood lipids and other CVD risk factors in a population of hypercholesterolemic men and women. Brit J Nutr. doi: 101017/S0007114507682968.
20. Ripsin CM, Keenan JM, Jacobs DR Jnr, Elmer PJ, Welch RR, Van Horn L, Liu K, Turnbull WH, Thye FW & Kestin M (1992) Oat products and lipid lowering: A meta-analysis. JAMA 267, 3317-3325.
21. Steffen LM, Jacobs JR, Stevens J, Shahar E, Carithers T & Folsom AR (2003) Associations of whole-grain, refined-grain, and fruit and vegetable consumption with risks of all-cause mortality and incident coronary artery disease and ischaemic stroke:tHe Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78, 383-390.
22. Törrönen R, Kansanen L, Uusitupa M, Hanninen O, Myllymaki O, Harkonen H & Malkki Y (1992) Effects of an oatbran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolemia. Eur J Clin Nutr 46, 621-627.
23. Wursch P & Pi-Sunyer FX (1997) The role of viscous soluble fibre in the metabolic control of diabetes - a review with special emphasis on cereals rich in beta-glucan. Diab Care 20, 1774-1780.